|
|
|
|
||
Re: $14 Billion Pfizer Buyout Worth About $85/share.Sorry to hear you weren't there till the proverbial end, but sounds like you made plenty. I was getting fidgety on this one as well, but luckily exercised patience enough to let the end game play itself out. Don't know WHAT Biomarin was thinking when they sold Talazoparib to Medivation. Ironic how they kept drisapersin (for Duchenne's), which they bought from Prosensa, and it ended up being a failure for them. Guess Biomarin is now the next one in play - with Sanofi and Roche being prominent mentions. Call options went crazy on that one today. No telling what other bidders there might be in addition. FYI - Sold all my shares of MDVN today. Good luck to all. |
return to message board, top of board |